RSLS חוב כולל להון ReShape Lifesciences Inc.

ReShape Lifesciences (RSLS) relies on the expertise of a tight-knit circle of leading developers, which, combined with high physician confidence in the safety of Lap-Band systems, strengthens the brand's position. This chart of the company's price action demonstrates the 0.02 metric. The stability of the medical devices' value is ensured by offering a gentle alternative to traditional weight-loss surgeries.

This ratio determines the degree of business dependence on borrowed funds by comparing total liabilities to net asset value to assess financial stability and default risks. For ReShape Lifesciences (RSLS), this balance is critical when financing the development of smart sensors and Lap-Band systems, reflecting the shifting proportion of total debt to equity.